These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Furey ML; Drevets WC Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814 [TBL] [Abstract][Full Text] [Related]
9. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study. Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885 [TBL] [Abstract][Full Text] [Related]
10. Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled study. Lemoine P; Boulenger JP; Caillard V; Tanne N; Bonnet D Pharmacopsychiatry; 1991 Sep; 24(5):175-9. PubMed ID: 1775523 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. Arana GW; Santos AB; Laraia MT; McLeod-Bryant S; Beale MD; Rames LJ; Roberts JM; Dias JK; Molloy M Am J Psychiatry; 1995 Feb; 152(2):265-7. PubMed ID: 7840362 [TBL] [Abstract][Full Text] [Related]
12. Intravenous pulse loading of clomipramine in adolescents with depression. Sallee FR; Pollock BG; Perel JM; Ryan ND; Stiller RL Psychopharmacol Bull; 1989; 25(1):114-8. PubMed ID: 2772110 [No Abstract] [Full Text] [Related]
13. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder. Alpert JE; Franznick DA; Hollander SB; Fava M J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591 [TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. Petracca G; Tesón A; Chemerinski E; Leiguarda R; Starkstein SE J Neuropsychiatry Clin Neurosci; 1996; 8(3):270-5. PubMed ID: 8854297 [TBL] [Abstract][Full Text] [Related]
15. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. Fallon BA; Liebowitz MR; Campeas R; Schneier FR; Marshall R; Davies S; Goetz D; Klein DF Arch Gen Psychiatry; 1998 Oct; 55(10):918-24. PubMed ID: 9783563 [TBL] [Abstract][Full Text] [Related]
16. Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders. Manna V; Martucci N; Agnoli A Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():81-8. PubMed ID: 2644342 [TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression. Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348 [TBL] [Abstract][Full Text] [Related]
18. A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression. Lépine JP; Goger J; Blashko C; Probst C; Moles MF; Kosolowski J; Scharfetter B; Lane RM Int Clin Psychopharmacol; 2000 Sep; 15(5):263-71. PubMed ID: 10993128 [TBL] [Abstract][Full Text] [Related]
19. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness. Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063 [TBL] [Abstract][Full Text] [Related]
20. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]